Home Healthcare Healthcare Services Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report By Scale of Operation (Commercial, Clinical, Preclinical), By Vaccine Type (Sub-attenuated Vaccines, Live-attenuated Vaccines, Inactivated Vaccines, Others), By Service (Fill/Finish, Analytical and QC Studies, Cell/Virus Banking, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
  7. North America Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
  8. Europe Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
  9. APAC Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
  10. Middle East and Africa Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
  11. LATAM Vaccine Contract Manufacturing Market Size Analysis
    1. Introduction
    2. Vaccine Contract Manufacturing Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Clinical
      3. Preclinical
    3. Vaccine Contract Manufacturing Market Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
      1. Sub-attenuated Vaccines
      2. Live-attenuated Vaccines
      3. Inactivated Vaccines
      4. Others
    4. Vaccine Contract Manufacturing Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Fill/Finish
      2. Analytical and QC Studies
      3. Cell/Virus Banking
      4. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Clinical
        3. Preclinical
      3. Market Size & Forecast By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Sub-attenuated Vaccines
        2. Live-attenuated Vaccines
        3. Inactivated Vaccines
        4. Others
      4. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Fill/Finish
        2. Analytical and QC Studies
        3. Cell/Virus Banking
        4. Others
  12. Competitive Landscape
    1. Vaccine Contract Manufacturing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Ajinomoto
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Albany Molecular Research
    3. Catalent
    4. Cytovance Biologics
    5. Emergent BioSolutions
    6. FUJIFILM Diosynth Biotechnologies
    7. GSK
    8. ICON
    9. IDT Biologika
    10. Lonza
    11. Merck KGaA
    12. Pfizer CentreOne
    13. Recipharm
    14. Siegfried
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.